{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "PROTALIX BIOTHERAP.DL-,01", "longName": "Protalix BioTherapeutics, Inc.", "messageBoardId": "finmb_941520", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.246, "averageDailyVolume3Month": 1030, "averageDailyVolume10Day": 2621, "fiftyTwoWeekLowChange": 1.1309999, "fiftyTwoWeekLowChangePercent": 1.1671826, "fiftyTwoWeekRange": "0.969 - 3.1", "fiftyTwoWeekHighChange": -1.0, "fiftyTwoWeekHighChangePercent": -0.32258067, "fiftyTwoWeekLow": 0.969, "fiftyTwoWeekHigh": 3.1, "earningsTimestamp": 1683203400, "earningsTimestampStart": 1683203400, "earningsTimestampEnd": 1683203400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.26, "epsForward": 0.04, "epsCurrentYear": -0.59, "priceEpsCurrentYear": -3.559322, "sharesOutstanding": 65414900, "bookValue": -0.198, "fiftyDayAverage": 2.06359, "fiftyDayAverageChange": 0.036409855, "fiftyDayAverageChangePercent": 0.017643938, "twoHundredDayAverage": 1.387683, "twoHundredDayAverageChange": 0.7123169, "twoHundredDayAverageChangePercent": 0.51331383, "marketCap": 156027888, "forwardPE": 52.5, "priceToBook": -10.60606, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -7.4074073, "regularMarketPrice": 2.1, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1213596000000, "priceHint": 4, "regularMarketChange": -0.16799998, "regularMarketTime": 1683907201, "regularMarketDayHigh": 2.4, "regularMarketDayRange": "2.099 - 2.4", "regularMarketDayLow": 2.099, "regularMarketVolume": 950, "regularMarketPreviousClose": 2.268, "bid": 2.093, "ask": 2.176, "symbol": "PBDA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2 University Plaza", "address2": "Suite 100", "city": "Hackensack", "state": "NJ", "zip": "07601", "country": "United States", "phone": "201 696 9345", "website": "https://www.protalix.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. It also develops PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is based in Hackensack, New Jersey. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.", "fullTimeEmployees": 193, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dror  Bashan", "age": 55, "title": "Pres, CEO & Director", "yearBorn": 1967, "fiscalYear": 2021, "totalPay": {"raw": 490104, "fmt": "490.1k", "longFmt": "490,104"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eyal  Rubin M.B.A.", "age": 46, "title": "Sr. VP, CFO, Treasurer & Corp. Sec.", "yearBorn": 1976, "fiscalYear": 2021, "totalPay": {"raw": 430561, "fmt": "430.56k", "longFmt": "430,561"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yaron  Naos", "age": 58, "title": "Sr. VP of Operations", "yearBorn": 1964, "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yael  Fellous", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}